[1]房 芳,于 宏.利拉鲁肽联合二甲双胍治疗2型糖尿病的疗效观察[J].医学信息,2022,35(16):141-143.[doi:10.3969/j.issn.1006-1959.2022.16.036]
　FANG Fang,YU Hong.Effect of Liraglutide Combined with Metformin in the Treatment of Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(16):141-143.[doi:10.3969/j.issn.1006-1959.2022.16.036]
点击复制

利拉鲁肽联合二甲双胍治疗2型糖尿病的疗效观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年16期
页码:
141-143
栏目:
药物与临床
出版日期:
2022-08-15

文章信息/Info

Title:
Effect of Liraglutide Combined with Metformin in the Treatment of Type 2 Diabetes Mellitus
文章编号:
1006-1959（2022）16-0141-03
作者:
房 芳; 于 宏
（天津市武清区人民医院内分泌科，天津 301700）
Author(s):
FANG Fang; YU Hong
(Department of Endocrinology,Wuqing District People’s Hospital,Tianjin 301700,China)
关键词:
利拉鲁肽; 二甲双胍; 2型糖尿病
Keywords:
Liraglutide; Metformin; Type 2 diabetes mellitus
分类号:
R587.1
DOI:
10.3969/j.issn.1006-1959.2022.16.036
文献标志码:
A
摘要:
目的 观察利拉鲁肽联合二甲双胍治疗2型糖尿病的临床疗效。方法 选取2020年3月-2021年3月在我院诊治的72例2型糖尿病患者为观察对象，采用随机数字表法分为对照组和观察组，各36例。对照组采用二甲双胍治疗，观察组在对照组基础上联合利拉鲁肽治疗，比较两组治疗总有效率、血糖指标、胰岛功能指标、炎症因子指标以及临床不良反应发生情况。结果 观察组治疗总有效率为94.44%，高于对照组的83.33%（P＜0.05）； 两组治疗后空腹血糖、餐后2h血糖、糖化血红蛋白水平均低于治疗前，且观察组低于对照组（P＜0.05）；两组治疗后空腹胰岛素（FINS）高于治疗前，胰岛素抵抗指数（HO-MA-IR）小于治疗前，且观察组FINS高于对照组，HOMAIR低于对照组（P＜0.05）；观察组不良反应发生率为5.56%，与对照组的8.33%比较，差异无统计学意义（P＞0.05）。结论 利拉鲁肽联合二甲双胍治疗2型糖尿病效果确切，可提高总有效率，降低空腹和餐后2h血糖以及糖化血红蛋白水平，改善胰岛功能，不良反应发生率低，可作为临床治疗2型糖尿病的有效联合用药方案。
Abstract:
Objective To observe the clinical effect of liraglutide combined with metformin in the treatment of type 2 diabetes mellitus.Methods A total of 72 patients with type 2 diabetes mellitus who were treated in our hospital from March 2020 to March 2021 were selected as the observational subjects. They were divided into control group and observation group by random number table method, with 36 cases in each group. The control group was treated with metformin, and the observation group was treated with liraglutide on the basis of the control group. The total effective rate, blood glucose index, islet function index, inflammatory factor index and clinical adverse reactions of the two groups were compared.Results The total effective rate of the observation group was 94.44%, which was higher than 83.33% of the control group (P<0.05). After treatment, fasting blood glucose, postprandial 2 h blood glucose and glycosylated hemoglobin levels in the two groups were lower than those before treatment, and those in the observation group were lower than the control group (P<0.05). The fasting insulin (FINS) of the two groups after treatment was higher than that before treatment, and the insulin resistance index (HOMAIR) was lower than that before treatment, and the FINS of the observation group was higher than that of the control group, and the HOMAIR was lower than that of the control group (P<0.05). the incidence of adverse reactions in the observation group was 5.56%, which was compared with 8.33% in the control group, The difference was not statistically significant(P>0.05).Conclusion Liraglutide combined with metformin is effective in the treatment of type 2 diabetes mellitus, which can improve the total effective rate, reduce fasting and postprandial 2 h blood glucose and glycated hemoglobin levels, improve islet function, and have low incidence of adverse reactions. It can be used as an effective combination regimen for clinical treatment of type 2 diabetes mellitus.

参考文献/References:

[1]王同兴.血清同型半胱氨酸和胱抑素C联合检测在2型糖尿病肾病诊断中的应用价值[J].医学检验与临床,2016,27(6):65-66.[2]路俊华.参芪降糖颗粒联合盐酸二甲双胍治疗2型糖尿病疗效分析[J].中国药业,2017,26(24):50-52.[3]高冬梅,包山丹.利拉鲁肽治疗对初发2型糖尿病伴肥胖患者代谢紊乱的调节作用[J].海南医学院学报,2017,23(16):2203-2206.[4]Hutchins J,Barajas RA,Hale D,et al.Type 2 diabetes in a 5-year-old and single center experience of type 2 diabetes in youth under 10[J].Pediatric Diabet,2017,18(7):674-677.[5]杨玉华,孙丽,王桂花,等.伏格列波糖联合利拉鲁肽治疗2型糖尿病的疗效观察[J].现代药物与临床,2017,32(8):1532-1535.[6]李燕妮,仲健,郭秋野,等.利拉鲁肽治疗2型糖尿病患者动脉粥样硬化的作用分析[J].解放军医药杂志,2017,29(9):71-74.[7]黄倩,张玲,李佳芮,等.利拉鲁肽联合胰岛素治疗老年难治性2型糖尿病的临床效果[J].中国老年学杂志,2017,37(21):5290-5291.[8]李勇,朱红霞,杨文翔,等.二甲双胍联合瑞格列奈治疗2型糖尿病的临床效果观察[J].中国医学前沿杂志(电子版),2017,9(10):125-127.[9]郑利星.加减乌梅汤联合盐酸二甲双胍治疗2型糖尿病的临床研究[J].山西医药杂志,2017,6(23):2835-2837.[10]郑陇军.糖维胶囊联合二甲双胍治疗2型糖尿病疗效及安全性观察[J].中国基层医药,2017,24(24):3771-3774.[11]曾俊,代文雪,梅希.单药或二联口服降糖药治疗血糖控制不佳的老年2型糖尿病患者加用达格列净的疗效及安全性[J].川北医学院学报,2021,36(6):749-752.[12]王芳,任汉强,沈晓波.利拉鲁肽联合二甲双胍对肥胖2型糖尿病患者临床效果及HOMA-β、HOMA-IＲ指数的影响[J].贵州医药,2016,40(11):1159-1161.[13]王宏涛,陈培红,丁花花.沙格列汀联合胰岛素泵短期强化降血糖治疗对2型糖尿病患者β细胞分泌功能及胰岛素抵抗的影响[J].药物评价研究,2019,42(11):2226-2229.[14]王静.利拉鲁肽联合盐酸二甲双胍片治疗2型糖尿病的临床疗效及安全观察[J].中南药学,2017,15(9):1321-1323.[15]杨杪,孙苏欣.初诊2型糖尿病应用二甲双胍分别联合地特岛素及利拉鲁肽的临床观察[J].中华临床医师杂志,2016,10(22):3469-3472.[16]张欣荣,薛有平,张凤强,等.恩格列净联合格列齐特治疗2型糖尿病的临床研究[J].现代药物与临床,2022,37(7):1565-1569.[17]杨群峰,聂芙蓉,徐伟良.二甲双胍联合利拉鲁肽治疗2型糖尿病的临床疗效及安全性分析[J].岭南急诊医学杂志,2016,21(1):40-42.[18]邓颖玉,施勇芳,黎碧霞.利拉鲁肽联合二甲双胍对2型糖尿病患者胰岛素与C肽水平的影响[J].慢性病学杂志,2017,18(9):997-998,1001.[19]刘中利.利拉鲁肽联合二甲双胍对2型糖尿病患者胰岛B细胞分泌功能的影响[J].中国疗养医学,2017,26(6):640-641.[20]周密,龚艳琳,李伟,等.利拉鲁肽联合二甲双胍治疗2型糖尿病合并冠心病的效果及对胰岛β细胞和心功能的影响[J].海军医学杂志,2020,41(2):196-198.

相似文献/References:

[1]刘 静.利拉鲁肽联合基础胰岛素对初诊2型糖尿病合并肥胖患者 血糖控制及体质量指数的影响[J].医学信息,2018,31(13):137.[doi:10.3969/j.issn.1006-1959.2018.13.040]
　LIU Jing.Effect of Liraglutide Combined with Basal Insulin on Blood Glucose Control and Body Mass Index in Newly Diagnosed Type 2 Diabetes Patients with Obesity[J].Journal of Medical Information,2018,31(16):137.[doi:10.3969/j.issn.1006-1959.2018.13.040]
[2]王晓刚.利拉鲁肽联合胰岛素泵对2 型糖尿病合并肝硬化患者血糖代谢及肝纤维化的影响[J].医学信息,2018,31(20):136.[doi:10.3969/j.issn.1006-1959.2018.20.041]
　WANG Xiao-gang.Effects of Liraglutide Combined with Insulin Pump on Blood Glucose Metabolism and Liver Fibrosis in Patients with Type 2 Diabetes Mellitus Complicated with Cirrhosis[J].Journal of Medical Information,2018,31(16):136.[doi:10.3969/j.issn.1006-1959.2018.20.041]
[3]刘朝阳,张善革.二甲双胍单药及不同联合用药方案治疗2型糖尿病的随机对照研究[J].医学信息,2019,32(04):148.[doi:10.3969/j.issn.1006-1959.2019.04.048]
　LIU Chao-yang,ZHANG Shan-ge.A Randomized Controlled Trial of Metformin Monotherapy and Different Combination Regimens in the Treatment of Type 2 Diabetes[J].Journal of Medical Information,2019,32(16):148.[doi:10.3969/j.issn.1006-1959.2019.04.048]
[4]苗 婷,刘子艳,刘玉媛,等.二甲双胍药理作用及其机制研究[J].医学信息,2019,32(14):53.[doi:10.3969/j.issn.1006-1959.2019.14.018]
　MIAO Ting,LIU Zi-yan,LIU Yu-yuan,et al.Study on Pharmacological Action and Mechanism of Metformin[J].Journal of Medical Information,2019,32(16):53.[doi:10.3969/j.issn.1006-1959.2019.14.018]
[5]金 川,张 颖,李瑞环,等.葛根芩连汤对2型糖尿病患者糖脂代谢指标及 体重的影响[J].医学信息,2019,32(14):164.[doi:10.3969/j.issn.1006-1959.2019.14.055]
　JIN Chuan,ZHANG Ying,LI Rui-huan,et al.Effect of Gegen Qinlian Decoction on Glucose and Lipid Metabolism Index and Body Weight in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2019,32(16):164.[doi:10.3969/j.issn.1006-1959.2019.14.055]
[6]曾小兵,朱长东,谢宝强.利拉鲁肽对首诊2型糖尿病患者血糖、血脂及T细胞亚群的影响[J].医学信息,2019,32(22):125.[doi:10.3969/j.issn.1006-1959.2019.22.041]
　ZENG Xiao-bing,ZHU Chang-dong,XIE Bao-qiang.Effect of Liraglutide on Blood Glucose,Blood Lipids and T cell Subsets in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2019,32(16):125.[doi:10.3969/j.issn.1006-1959.2019.22.041]
[7]尤 丽,卢 琦.甘精胰岛素联合二甲双胍治疗2型糖尿病的疗效[J].医学信息,2020,33(02):151.[doi:10.3969/j.issn.1006-1959.2020.02.046]
　YOU Li,LU Qi.Effect of Insulin Glargine Combined with Metformin in the Treatment of Type 2 Diabetes[J].Journal of Medical Information,2020,33(16):151.[doi:10.3969/j.issn.1006-1959.2020.02.046]
[8]王海燕,毕雪玲,曹 晶,等.坤泰胶囊联合炔雌醇环丙孕酮片、二甲双胍治疗多囊卵巢综合征的效果及对性激素的影响[J].医学信息,2020,33(20):129.[doi:10.3969/j.issn.1006-1959.2020.20.039]
　WANG Hai-yan,BI Xue-ling,CAO Jing,et al.The Effect of Kuntai Capsule Combined with Ethinyl Estradiol and Cyproterone Tablets and Metformin in the Treatment of Polycystic Ovary Syndrome and Its Influence on Sex Hormones[J].Journal of Medical Information,2020,33(16):129.[doi:10.3969/j.issn.1006-1959.2020.20.039]
[9]张月田,刘世平.二甲双胍治疗2型糖尿病的不良反应及联合用药的应用[J].医学信息,2021,34(06):64.[doi:10.3969/j.issn.1006-1959.2021.06.017]
　ZHANG Yue-tian,LIU Shi-ping.Adverse Reactions of Metformin in the Treatment of Type 2 Diabetes and the Application of Combined Medication[J].Journal of Medical Information,2021,34(16):64.[doi:10.3969/j.issn.1006-1959.2021.06.017]
[10]王晓洲,吴仰帆,栾晓军.利拉鲁肽对肥胖T2DM患者促炎-抗炎系统及左心舒张功能的影响[J].医学信息,2021,34(22):145.[doi:10.3969/j.issn.1006-1959.2021.22.045]
　WANG Xiao-zhou,WU Yang-fan,LUAN Xiao-jun.Effects of Liraglutide on Pro-inflammatory-anti-inflammatory System and Left Ventricular Diastolic Function in Obese T2DM Patients[J].Journal of Medical Information,2021,34(16):145.[doi:10.3969/j.issn.1006-1959.2021.22.045]

更新日期/Last Update: 1900-01-01